Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trained immunity refers to the phenomenon where innate immune cells develop a long-lasting enhanced response after exposure to certain stimuli, including vaccines like BCG. This process is mediated by epigenetic and metabolic reprogramming of innate immune cells via pattern recognition receptors (PRRs) such as TLR2, TLR4 and NOD2 upon recognition of mycobacterial PAMPs. The net effect is an enhanced non-specific response to subsequent infections, driven by increased production of pro-inflammatory cytokines and improved innate defenses.
Activation of PRRs (NOD2, TLR2, TLR4) by BCG leading to intracellular signaling, epigenetic remodeling, metabolic rewiring, and enhanced cytokine production upon secondary stimulation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trained Immunity Induction via Pattern Recognition Receptor (for BCG) (N/A).